First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.

Pim B van der MeerLinda DirvenMarta FioccoMaaike J VosMathilde C M KouwenhovenMartin J van den BentMartin J B TaphoornJohan A F Koekkoek

Published in: Epilepsia (2021)

Our results suggest that levetiracetam may have favorable efficacy compared to valproic acid, whereas level of toxicity seems similar. Therefore, levetiracetam seems to be the preferred choice for first-line AED treatment in patients with glioma.

Keyphrases

oxidative stress
emergency department
combination therapy
adverse drug